Wednesday, 9 October 2013

Copanlisib (BAY 80-6946), Bayer’s novel, oral phosphatidylinositol-3 kinases (PI3K) inhibitor « New Drug Approvals

Copanlisib (BAY 80-6946), Bayer’s novel, oral phosphatidylinositol-3 kinases (PI3K) inhibitor « New Drug Approvals:

'via Blog this'

No comments:

Post a Comment